Trial Profile
Stiripentol (diacomit(R)) for refractory epilepsy patients with autoimmune encephalitis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Stiripentol (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- 30 Aug 2016 New trial record